Despite the rich literature and large number of guideline and consensus statements the management of patients with Barrett’s Esophagus (BE) remains controversial and demands careful thought when face-to-face with a patient. The approach to screening, individualized risk assessment and treatment depends on the scope of your practice, your access to technology, pathology and a multidisciplinary team. I am an interventional endoscopist with a specialized referral practice in foregut disease. In this article I discuss how I approach a patient with suspected or known Barrett’s Esophagus.
SharmaPShaheenNJKatzkaDBergmanJJGHM. AGA clinical practice update on endoscopic treatment of Barrett’s esophagus with dysplasia and/or early cancer: expert review. Gastroenterology. 2020;158(3):760-769.
2.
QumeseyaBSultanSBainP. ASGE guideline on screening and surveillance of Barrett’s esophagus. Gastrointest Endosc. 2019;90(3):335-359.
3.
OrmanESLiNShaheenNJ. Efficacy and durability of radiofrequency ablation for Barrett’s esophagus: systemic review and metanalysis. Clin Gastroenterol Hepatol. 2013; 11:1245-1255.
4.
ParasaSVennalagantiSGaddamS, et al. Development and validation of a model to determine risk of progression of barrett’s esophagus to neoplasia. Gastroenterology. 2018;154:1282-1289.
5.
CottonCCHaidryRThriftAP. Development of evidence-based surveillance intervals after radiofrequency ablation of Barrett’s esophagus. Gastroenterology. 2018;155:316-326.
6.
ShaheenNJFalkGWIyerPGGersonLB. American College of Gastroenterology. ACG clinical guideline: diagnosis and management of Barrett’s esophagus. Am J Gastroenterol. 2016;111(1):30-50.
7.
SharmaPDentJArmstrongD. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology. 2006;131(5):1392-1399.
8.
SamiSSRavindranAKahnA. Timeline and location of recurrence following successful ablation in Barrett’s oesophagus: an international multicentre study. Gut2019;68(8):1379-1385.
